Chemoinformaics analysis of 13E-Octadecenoic acid Methyl Ester
| Molecular Weight | 296.495 | nRot | 15 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 2 |
| Exact Molecular Weight | 296.272 | nRing | 0 |
| Solubility: LogS | -6.715 | nHRing | 0 |
| Solubility: LogP | 7.53 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 57.3385 |
| nHD | 0 | BPOL | 38.7195 |
| QED | 0.204 |
| Synth | 2.092 |
| Natural Product Likeliness | 0.795 |
| NR-PPAR-gamma | 0.249 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.006 |
| HIA | 0.004 |
| CACO-2 | -4.702 |
| MDCK | 0.0000165 |
| BBB | 0.179 |
| PPB | 0.972473 |
| VDSS | 3.02 |
| FU | 0.0182152 |
| CYP1A2-inh | 0.714 |
| CYP1A2-sub | 0.194 |
| CYP2c19-inh | 0.47 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.313 |
| CYP2c9-sub | 0.952 |
| CYP2d6-inh | 0.176 |
| CYP2d6-sub | 0.092 |
| CYP3a4-inh | 0.534 |
| CYP3a4-sub | 0.055 |
| CL | 5.702 |
| T12 | 0.262 |
| hERG | 0.249 |
| Ames | 0.005 |
| ROA | 0.012 |
| SkinSen | 0.97 |
| Carcinogencity | 0.111 |
| EI | 0.962 |
| Respiratory | 0.732 |
| NR-Aromatase | 0.08 |
| Antiviral | No |
| Prediction | 0.615482 |